A more recent phase II study randomized 164 patients with untreated SCLC to four possible treatment arms: chemotherapy alone (carboplatin, ifosphamide, and etoposide) or combined with IFN-α, IFN-γ, or IFN-α plus IFN-γ (34). Here, IFNG is linked to small cell lung carcinoma.